Antibody-mediated TGF-ß1 activation for the treatment of diseases caused by deleterious T cell activity

Lambert, Fanny; Jan Felix; Wautier, Séverine; Dupre, Emilie; Jamez, Mathieu; Michiels, Camille; Mélanie Gaignage; Lore Mariën; Manon Lesage; Bas van der Woning; Savvas Savvides; Lucas, Sophie

Antibody-mediated TGF-ß1 activation for the treatment of diseases caused by deleterious T cell activity

Lambert, Fanny

;

Jan Felix

;

Wautier, Séverine

;

Dupre, Emilie

;

Lucas, Sophie

;et.al.

(2025) Cell Reports — Vol. 44, n° 8, p. 116061 (2025)

Files

2025LambertCellReports.pdf

Open Access
Adobe PDF
8.01 MB

Download

Details

Authors

Lambert, FannyUCLouvain
Author
Jan Felix
Author
Wautier, SéverineUCLouvain
Author
Dupre, EmilieUCLouvain
Author
Jamez, MathieuUCLouvain
Author
Michiels, CamilleUCLouvain
Author
Lucas, SophieUCLouvain
Author

Affiliations

UCLouvainSSS/DDUV/GECE - Génétique cellulaire

Citations

APA
Chicago
FWB

Lambert, F., Jan Felix, Wautier, S., Dupre, E., Jamez, M., Michiels, C., Mélanie Gaignage, Lore Mariën, Manon Lesage, Bas van der Woning, Savvas Savvides, & Lucas, S. (2025). Antibody-mediated TGF-ß1 activation for the treatment of diseases caused by deleterious T cell activity. Cell Reports, 44(8), 116061. (Original work published 2025)